drugset / Trial / NCT04865744

The Effect of Semaglutide on Pituitary Function

NCT04865744

Phase 4 Completed 10 enrolled University of Tartu
RandomizedCrossoverDouble-blindDiagnostic

Summary

The primary aim of the study is to describe the effect of a single oral dose of semaglutide 7 mg on growth hormone secretion.

Timeline

Start
2021-05-19
Primary completion
2021-09-23
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Semaglutide Peptide 7 mg Oral
Comparator Semaglutide Peptide 14 mg Oral

Indications

No indication recorded.